Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma

Georgiou, Marina; Ntavelou, Panagiota; Stokes, William; Roy, Rajat; Maher, Geoffrey J.; Stoilova, Tsvetana; Choo, Josephine A.M.Y.; Rakhit, Callum P.; Martins, Miguel; Ajuh, Paul; Horowitz, Neil; Berkowitz, Ross S.; Elias, Kevin; Seckl, Michael J.; Pardo, Olivier E.

View / Open Files

Published version (PDF, 306Kb)

Bibliographic metadata (XML, 13Kb)

Authors

Georgiou, Marina

Ntavelou, Panagiota

Stokes, William

Roy, Rajat

Maher, Geoffrey J.

Stoilova, Tsvetana

Choo, Josephine A.M.Y.

Publication Date

2022-05-30

Journal Title

Oncogene

ISSN

0950-9232

Publisher

Nature Publishing Group UK

Volume

Issue

Pages

3510-3510

Language

Type

Other

This Version

VoR

Metadata

Show full item record

Citation

Georgiou, M., Ntavelou, P., Stokes, W., Roy, R., Maher, G. J., Stoilova, T., Choo, J. A., et al. (2022). Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. [Other]. https://doi.org/10.1038/s41388-022-02354-2

Keywords

Correction, /631/67/1059/2326, /631/67/1517, correction

Identifiers

s41388-022-02354-2, 2354

External DOI: https://doi.org/10.1038/s41388-022-02354-2

This record's DOI: https://doi.org/10.17863/CAM.85929

Rights

Licence:

http://creativecommons.org/licenses/by/4.0/

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.